The use of platelet function assays may help to determine appropriate antiplatelet treatment options in a patient with recurrent stroke on baby aspirin: Against

Stroke

Volumn 41, Issue 10, 2010, Pages 2398-2399

  Eikelboom, John W ^a   Emery, Jon ^b   Hankey, Graeme J ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11 OXOTHROMBOXANE B2; ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; THROMBOXANE B2 DERIVATIVE; WARFARIN; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; BRAIN ISCHEMIA; DRUG EFFICACY; DRUG MECHANISM; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FUNCTION TEST; GASTROINTESTINAL HEMORRHAGE; HUMAN; LOW DRUG DOSE; PRIORITY JOURNAL; RECURRENT DISEASE; RELIABILITY; SHORT SURVEY; STANDARDIZATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; URINE LEVEL; BLOOD CLOTTING PARAMETERS; STROKE;

ASPIRIN; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; RECURRENCE; STROKE;

EID: 77958018644     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.593582     Document Type: Short Survey

References (6)

1. Algra A, van Gijn J. Cumulative meta-analysis of aspirin efficacy after cerebral ischemia of arterial origin. J Neurol Neurosurg Psychiatry. 1999; 66:255.
2. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005;353: 2373-2383.
3. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet. 2006;367: 606-617.
4. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-1860.
5. Serebruany V. Dose of aspirin and bleeding risks. Am J Cardiol. 2006; 98:275.
6. Hankey GJ, Eikelboom JW. Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. Lancet Neurol. 2010;9:273-284.